Trial Transparency Starts Here: Trial Summaries

Regulatory, clinical operations, and patient engagement teams responsible for returning trial results to participants can use Trial Summaries to meet growing legal and ethical obligations under EU Regulation 536/2014, the UK Clinical Trials Regulation, and ICH E6(R3), which require plain-language results to be shared in a way participants can understand. Sponsors can post summaries securely to a single, non-promotional, brand-agnostic portal that reaches visitors in more than 170 countries and supports over 250 languages, replacing costly and unreliable paper-based distribution at study sites. With 78% of participants wanting a summary of results but only 35% currently receiving one, teams can expect improved participant communication, simplified compliance tracking, and reduced administrative burden through features like automated email alerts and integration with existing disclosure workflows. For organizations looking to close this communication gap while meeting global transparency requirements, this offers a reliable path to fulfilling both regulatory obligations and participant expectations.